Close Menu

gene silencing

Gladstone Institutes researchers will use proteomic, genomic, and gene-altering approaches to investigate apoe4 toxicity as part of a five-year project.

Findings from a genome-wide association study suggest that fetal SNPs in SLIT2 and other genes may coincide with the risk of spontaneous preterm birth.

The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has signed a supply and distribution agreement enabling it to offer its customers access to Sirion Biotech's RNAiONE custom short hairpin RNA development services.

Dicerna Pharmaceuticals announced this week that it has taken a non-exclusive license to RNAi intellectual property held by Plant Bioscience Limited.

A study published in Nature Genetics last month has identified a genetic variant strongly associated with higher risk of certain brain tumors, and suggests the involvement of a long non-coding RNA or a microRNA.

Alnylam Pharmaceuticals this week announced that it has taken a non-exclusive license to RNAi-related intellectual property held by UK technology management firm Plant Bioscience Limited.

The company has added respiratory and inflammation to an RNAi screening program that began with oncology.

Papers of Note for April 2009

Premium

RNAi-Related Papers Published April 2009

Richard Chin, John Rossi, Alice Lin-Tsing, Kenneth Reed

Pages

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.